Medicina
Departamento
Ankara University
Ankara, TurquíaPublicaciones en colaboración con investigadores/as de Ankara University (19)
2024
2023
-
Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis
Psychological Assessment, Vol. 35, Núm. 2, pp. 94-114
-
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer
2022
2021
-
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 6, pp. 801-812
-
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Vol. 15, Núm. 6, pp. 879-913
2020
-
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
Blood, Vol. 136, Núm. 26, pp. 3033-3040
-
EAACI-Leitlinien zur allergen-spezifischen Immuntherapie: Insektengiftallergie
Allergologie, Vol. 43, Núm. 5, pp. 176-203
-
Survey of the impact of COVID-19 on oncologists' decision making in cancer
JCO Global Oncology, pp. 1248-1257
2019
-
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
The Lancet Infectious Diseases, Vol. 19, Núm. 9, pp. 988-1000
2018
-
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 744-764
-
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 18, Núm. 10, pp. e401-e419
-
Toxoplasmosis in transplant recipients, Europe, 2010–2014
Emerging Infectious Diseases, Vol. 24, Núm. 8, pp. 1497-1504
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
2014
-
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
American Journal of Hematology, Vol. 89, Núm. 4, pp. 355-362
-
Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels
BMC Infectious Diseases, Vol. 14, Núm. 1
2013
-
Macitentan for the treatment of idiopathic pulmonary fibrosis: The randomised controlled MUSIC trial
European Respiratory Journal, Vol. 42, Núm. 6, pp. 1622-1632
2011
-
Bevacizumab treatment for advanced breast cancer
Oncologist, Vol. 16, Núm. 12, pp. 1684-1697